Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Becton, Dickinson and Company (BDX)

248.47   -5.7 (-2.24%) 02-02 16:00
Open: 239.17 Pre. Close: 254.17
High: 257.69 Low: 237
Volume: 2,751,337 Market Cap: 70,632(M)

Technical analysis

as of: 2023-02-02 4:29:05 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 294.94     One year: 306.78
Support: Support1: 236.11    Support2: 196.44
Resistance: Resistance1: 252.51    Resistance2: 262.66
Pivot: 251.72
Moving Average: MA(5): 251.36     MA(20): 252.72
MA(100): 240.74     MA(250): 248.89
MACD: MACD(12,26): -0.1     Signal(9): 0.4
Stochastic oscillator: %K(14,3): 64.5     %D(3): 59
RSI: RSI(14): 45.5
52-week: High: 277.29  Low: 215.89
Average Vol(K): 3-Month: 1,377 (K)  10-Days: 1,146 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ BDX ] has closed above bottom band by 24.0%. Bollinger Bands are 42.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 257.99 - 259.35 259.35 - 260.51
Low: 233.09 - 234.53 234.53 - 235.76
Close: 245.99 - 248.55 248.55 - 250.73

Company Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Headline News

Thu, 02 Feb 2023
Int'l Bytes: Prime, BDx, Liquid, Nokia, Web Werks, Iron Mountain - Telecom Ramblings

Thu, 02 Feb 2023
Becton Dickinson (BDX) Tops Q1 Earnings and Revenue Estimates - Nasdaq

Wed, 01 Feb 2023
BDx to Develop a New 16MW Data Center in Hong Kong's ... - PR Newswire

Wed, 01 Feb 2023
Pre-Market Earnings Report for February 2, 2023 : LLY, MRK, BMY ... - Nasdaq

Wed, 01 Feb 2023
MedTech Stocks' Earnings to Watch on Feb 2: BDX, DGX & CNMD - Yahoo Finance

Tue, 31 Jan 2023
BDX Unveils Enhanced Home Shopper Experience For ... - PR Web

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 284 (M)
Shares Float 283 (M)
% Held by Insiders 0.3 (%)
% Held by Institutions 91 (%)
Shares Short 1,990 (K)
Shares Short P.Month 2,230 (K)

Stock Financials

EPS 5.38
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 89.22
Profit Margin (%) 9.4
Operating Margin (%) 13.9
Return on Assets (ttm) 3
Return on Equity (ttm) 6.6
Qtrly Rev. Growth -1.8
Gross Profit (p.s.) 30.28
Sales Per Share 66.38
EBITDA (p.s.) 17.09
Qtrly Earnings Growth 12.1
Operating Cash Flow 2,770 (M)
Levered Free Cash Flow 1,820 (M)

Stock Valuations

PE Ratio 46.18
PEG Ratio 2.3
Price to Book value 2.78
Price to Sales 3.74
Price to Cash Flow 25.49

Stock Dividends

Dividend 0.91
Forward Dividend 0
Dividend Yield 0.3%
Dividend Pay Date 2021-12-30
Ex-Dividend Date 2021-12-08
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.